Parallax Volatility Advisers’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-803
Closed -$78.1K 1973
2024
Q4
$78.1K Buy
+803
New +$85.6K ﹤0.01% 1752
2022
Q1
Sell
-138,997
Closed -$12.2M 3033
2021
Q4
$12.2M Buy
138,997
+135,356
+3,718% +$11.2M 0.01% 545
2021
Q3
$298K Buy
+3,641
New +$328K ﹤0.01% 1633
2021
Q1
Sell
-57
Closed -$5K 1988
2020
Q4
$5K Sell
57
-766
-93% -$66.9K ﹤0.01% 2153
2020
Q3
$72K Buy
823
+807
+5,044% +$69.9K ﹤0.01% 2784
2020
Q2
$1K Buy
+16
New +$1.38K ﹤0.01% 2665
2020
Q1
Sell
-2,438
Closed -$218K 2642
2019
Q4
$231K Sell
2,438
-5,554
-69% -$498K ﹤0.01% 1977
2019
Q3
$695K Sell
7,992
-167,931
-95% -$15.1M ﹤0.01% 1519
2019
Q2
$16.1M Sell
175,923
-33,567
-16% -$2.84M 0.02% 415
2019
Q1
$18M Buy
209,490
+208,854
+32,839% +$16.8M 0.02% 337
2018
Q4
$49K Sell
636
-85,244
-99% -$6.64M ﹤0.01% 2132
2018
Q3
$6.63M Buy
+85,880
New +$6.35M 0.01% 613

Other funds holding NVS

Parallax Volatility Advisers's NVS Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of Novartis (NVS) in Q1 2025, closing a stake of 803 shares — an estimated $78.1K sold.

Parallax Volatility Advisers first reported a position in NVS in Q3 2018 and held it in 12 quarters. The position peaked at $18M in Q1 2019. 1,356 funds tracked by Wall St. Rank hold NVS as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining Novartis position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 803 Novartis shares in Q1 2025, an estimated $78.1K.
  • Parallax Volatility Advisers first reported a position in Novartis in Q3 2018 and held it in 12 quarters.
  • Parallax Volatility Advisers's Novartis position peaked at $18M in Q1 2019.
  • 1,356 funds tracked by Wall St. Rank held Novartis as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.